信息搜索
信息关键字：药
  
『查询2022年信息』  『查询2021年信息』  『查询2020年信息』  『查询2019年信息』  『查询2018年信息』  『查询2017年信息』  『查询2016年信息』
『查询2015年信息』  『查询2014年信息』  『查询2013年信息』  『查询2012年信息』  『查询2011年信息』  『查询2010年信息』  『查询2009年信息』

分页[1] [2] [3] [4] [5] [6] [7] [8] [9] [10] [11] [12] [13] [14] [15] [16] [17] [18] [19] [20] [21] [22] [23] [24] [25] [26] [27] [28] [29] [30] [31] [32] [33] [34] [35] [36] [37] [38] [39] [40] [41] [42] [43] [44] [45] [46] [47] [48] [49] [50] [51] [52] [53] [54] [55] [56] [57] [58] [59] [60] [61] [62] [63] [64] [65] [66] [67] [68] [69] [70] [71] [72] [73] [74] [75] [76] [77] [78] [79] [80] [81] [82] [83] [84] [85] [86] [87] [88] [89] [90] [91] [92] [93] [94] [95] [96] [97] [98] [99] [100] [101] [102] [103] [104] [105] [106] [107] [108] [109] [110] [111] [112] [113] [114] [115] [116] [117] [118] [119] [120] [121] [122] [123] [124] [125] [126] [127] [128] [129] [130] [131] [132] [133] [134] [135] [136] [137] [138] [139] [140] [141] [142] [143] [144] [145] [146] [147] [148] [149] [150] [151] [152] [153] [154] [155] [156] [157] [158] [159] [160] [161] [162] [163] [164] [165] [166] [167] [168] [169] [170] [171] [172] [173] [174] [175] [176] [177] [178] [179] [180] [181] [182] [183] [184] [185] [186] [187] [188] [189] [190] [191] [192] [193] [194] [195] [196] [197] [198] [199] [200] [201] [202] [203] [204] [205] [206] [207] [208] [209] [210] [211] [212] [213] [214] [215] [216] [217] [218] [219] [220] [221] [222] [223] [224] [225] [226] [227] [228] [229] [230] [231] [232] [233] [234] [235] [236] [237] [238] [239]

·血浆不够水稻来“凑”？禾元生物三年半亏近3亿，申报前夕贝达药业突击入股2023-9-11 14:34:14
·医药生物行业周报：2022年度药品审评报告发布，关注中药、儿童药发展机会2023-9-11 13:48:25
·医药生物行业跟踪周报：老龄化促使带疱疫苗空间广阔，推荐智飞生物2023-9-11 12:46:00
·恒瑞医药羟乙磺酸达尔西利片、醋酸阿比特龙片（I）获得药物临床试验批准2023-9-11 12:45:32
·科伦药业：控股子公司科伦博泰开发的A140注射液上市申请获CDE受理2023-9-11 12:41:24
·医药行业周报：医药中报落地，业绩分化2023-9-11 12:24:46
·A股午评：沪指震荡反弹半日涨0.57% 减肥药概念股领涨两市2023-9-11 11:33:44
·拥抱全渠道时代，2023伯云会邀你共探全球化视野下的中国医药产业发展2023-9-11 10:32:09
·创新药概念股持续拉升2023-9-11 9:51:43
·创新药概念股盘初拉升2023-9-11 9:39:12
·中泰证券：特色原料药板块有望保持持续增长态势2023-9-11 8:36:29
·赤天化“卖药买矿”资产置换计划被上交所火速问询2023-9-11 1:14:37
·兴齐眼药的阿托品业绩支柱还能撑得住高股价吗？2023-9-10 22:27:12
·科伦药业：A140注射液上市申请获NMPA受理2023-9-10 16:51:13
·天坛生物：子公司注射用重组人凝血因子Ⅷ获药品注册证书，相关生产场地通过药品GMP符合性检查2023-9-10 15:52:08
·恒瑞医药：获得药物临床试验批准通知书2023-9-10 15:43:44
·广药集团与兰州市政府签署战略合作框架协议2023-9-10 8:49:05
·1股获买入评级 最新:复星医药 2023-9-10 8:26:02
·生物医药迎“回购潮”：“生长激素第一股”长春高新拟以约2亿资金回购公司股份2023-9-8 20:20:03
·医药生物行业上市公司2023年中报综述：分化中成长，徘徊中复苏2023-9-8 18:59:33

分页[1] [2] [3] [4] [5] [6] [7] [8] [9] [10] [11] [12] [13] [14] [15] [16] [17] [18] [19] [20] [21] [22] [23] [24] [25] [26] [27] [28] [29] [30] [31] [32] [33] [34] [35] [36] [37] [38] [39] [40] [41] [42] [43] [44] [45] [46] [47] [48] [49] [50] [51] [52] [53] [54] [55] [56] [57] [58] [59] [60] [61] [62] [63] [64] [65] [66] [67] [68] [69] [70] [71] [72] [73] [74] [75] [76] [77] [78] [79] [80] [81] [82] [83] [84] [85] [86] [87] [88] [89] [90] [91] [92] [93] [94] [95] [96] [97] [98] [99] [100] [101] [102] [103] [104] [105] [106] [107] [108] [109] [110] [111] [112] [113] [114] [115] [116] [117] [118] [119] [120] [121] [122] [123] [124] [125] [126] [127] [128] [129] [130] [131] [132] [133] [134] [135] [136] [137] [138] [139] [140] [141] [142] [143] [144] [145] [146] [147] [148] [149] [150] [151] [152] [153] [154] [155] [156] [157] [158] [159] [160] [161] [162] [163] [164] [165] [166] [167] [168] [169] [170] [171] [172] [173] [174] [175] [176] [177] [178] [179] [180] [181] [182] [183] [184] [185] [186] [187] [188] [189] [190] [191] [192] [193] [194] [195] [196] [197] [198] [199] [200] [201] [202] [203] [204] [205] [206] [207] [208] [209] [210] [211] [212] [213] [214] [215] [216] [217] [218] [219] [220] [221] [222] [223] [224] [225] [226] [227] [228] [229] [230] [231] [232] [233] [234] [235] [236] [237] [238] [239]